Addex Therapeutics Ltd. financial data

Symbol
ADXN on Nasdaq
Location
Chemin Des Mines 9, Geneva, Switzerland
State of incorporation
Switzerland
Fiscal year end
December 31
Latest financial report
20-F - Q4 2023 - Apr 18, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 125M shares +62.3%

Income Statement

Label TTM Value / Value Unit Change %
Research And Development Expense 1.88M CHF -67.4%
General And Administrative Expense 1.3M CHF -14.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets 4.64M CHF -44%

Popular Metrics

Label TTM Value / Value Unit Change %
Interest Expense 93 CHF -98.8%